baber/WOPTO huggingface dataset:
Patent NZ-544065-A (NZ)
Title: Electronic security system for monitoring and recording activity and data relating to cargo
Inventor: SAJKOWSKY JAMES M
IPC: G06Q10/08
Filed: 2004-06-17
Abstract: A tracking system is disclosed for identifying contents of a container, wherein the container has an associated data set indicative of its contents and parameters. The system comprises an electromagnetic identification apparatus providing a signal indicative of the container data set, a writer for encoding the signal onto the identification apparatus, a controller for receiving the coded signal and storing the signal in a master database, a reader outside of the container for communicating with the identification apparatus and receiving the signal and providing the signal to the controller. The electromagnetic identification apparatus includes a plurality of identification tags (915 MHz RFID tags), each tag associated with a corresponding element within the container. An aggregate electromagnetic signature signal is generated. Also disclosed is a system for tracking items in an assembly, a system for managing items in a collection, and a method for managing items in a collection.
Patent NZ-548302-A (NZ)
Title: Novel combination of anticholinergic and beta mimetics for the treatment of respiratory diseases
Inventor: GOEDE JOACHIM
IPC: A61K9/00
Filed: 2005-01-24
Abstract: Disclosed is a use of a combination of R,R-glycopyrrolate or one of its physiologically acceptable salts and a long-acting beta 2-mimetic agent selected from the group comprising formoterol and salmeterol or a physiologically acceptable salt thereof for the production of a medicament for the treatment of asthma or COPD.Also disclosed is a process of production of the medicament incorporating the said combination.
Patent NZ-555981-A (NZ)
Title: Crystalline forms of (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride
Inventor: AGARWAL RAJESH KUMAR
IPC: A61K31/55
Filed: 2005-12-20
Abstract: Disclosed is the compound (R)-8-chloro-1-methyl-2,3,4,5-tetrahydro-1H-3-benzazepine hydrochloride hemihydrate. Physical characteristics of the said compound using X-ray powder diffraction and differential scanning calorimetry trace are also disclosed. Also disclosed is the use of the said compound in the manufacture of a medicament for the treatment of obesity.
Patent NZ-556065-A (NZ)
Title: FC-fusion constructs binding to phosphatidylserine and their therapeutic use
Inventor: THORPE PHILIP E
Filed: 2006-01-24
Abstract: Disclosed is a phosphatidylserine binding construct comprised of an antibody Fc reion operatively attached to a beta2-glycoprotein I (beta2GPI). The construct binds phosphatidylserine in disease and enhances its destruction. It can also specifically deliver attached imaging or therapeutic agents to the disease site. Also disclosed are methods of using the construct composition, therapeutic conjugates and combinations thereof in the manufacture of medicaments for treating tumour vasculature targeting, cancer diagnosis and treatment, and for treating viral infections and other diseases.
Patent NZ-556356-A (NZ)
Title: Spinal fixing device
Inventor: KLOSS HENNING
IPC: A47L9/24
Filed: 2006-02-08
Abstract: The disclosure relates to a vertebral column stabilising device comprising at least two pedicle screws and at least one connecting element therebetween. Said invention also relates to pedicle screws which combine advantages of monoaxial and polyaxial screws in such a way that disadvantages thereof are avoided. For this purpose, the screw head is fixedly mounted on the screw shaft in order to ensure an optimal replacement of vertebra, wherein a movable spherical element arranged in the screw head eases the introduction of a connection element through the screw head and is fixedly connectable thereto after a successful introduction.
Patent NZ-562428-A (NZ)
Title: Truck suspensions incorporating asymmetric leaf springs
Inventor: DUDDING ASHLEY T
IPC: F16F3/00
Filed: 2001-05-11
Abstract: A suspension system for supporting fore-and aft extending frame members of a vehicle chassis on a hollow axle, the system on one side of the vehicle being duplicated on the opposite side. Included in the suspension on each side are: a frame bracket for pivotally supporting the fore or leading end of an asymmetric leaf spring; a spring end support mounted on the frame side member for supporting the aft or trailing end of the leaf spring, and (3) a suitable assembly for attaching the leaf spring at a location intermediate its opposite ends to the axle so that the spring is divided into two cantilever limbs extending in opposite directions from the center line of the axle. The spring is formed so that one of the cantilever limbs has a stifness substantially greater than the stiffness of the other limb. In all forms, at least one leaf of the asymmetric spring extends the full length of the spring. In one particular form the spring has a shorter leaf with an end portion extending over the axle with an air spring mounted either directly over the axle or on one side of the axle. Instead of having two leafs, the asymmetric spring may be formed as a tapered convolute single-leaf spring. (62) Divided Out of 546357
Patent NZ-570334-A (NZ)
Title: Compounds for the treatment of metabolic disorders
Inventor: SHARMA SHALINI
IPC: A61K31/075
Filed: 2007-02-01
Abstract: Disclosed is the use of a compound of formula I, where the substituents and variables are as defined in the specification, to treat insulin resistance syndrome, diabetes including Type I Diabetes and Type II Diabetes, polycystic ovary syndrome, atherosclerosis, arteriosclerosis, obesity, hypertension, hyperlipidemia, fatty liver disease, nephropathy, neuropathy, retinopathy, foot ulceration or cataracts associated with diabetes hyperlipidemia, cachexia, or obesity.
Patent NZ-572299-A (NZ)
Title: Combination comprising a substituted 3,5-diphenyl-1,2,4-triazole and a platinum compound and use thereof
Inventor: NICK HANSPETER
IPC: A61K33/243
Filed: 2007-05-08
Abstract: Disclosed is a combination comprising (a) a substituted 3,5-diphenyl-1,2,4-triazole such as 4-[3,5-bis(2-hydroxyphenyl)-[1,2,4]triazol-1-yl]benzoic acid, and at least one platinum antineoplastic agent, and the use of said combination for the preparation of a medicament for the treatment of proliferative diseases.
Patent NZ-574013-A (NZ)
Title: Stainless steel wire having a flux core used for welding zinc based alloy coated steel steet
Inventor: MIZUMOTO MANABU
IPC: B23K9/23
Filed: 2007-07-04
Abstract: The stainless steel wire having a flux core used for welding zinc-based alloy coated steel sheet is disclosed. The alloy components in the welding material are defined by F value in the range from 30 to 50. The flux comprises Al2O3 whose mass is between the range of 0.1-1.0% of the total mass of the wire. The claimed invention makes it is possible to inhibit zinc embrittlement cracks, in addition to making an arc stable, which results in improved welding workability.
Patent NZ-574919-A (NZ)
Title: A toilet pan installation bracket fixed to a wall with two pipe clamps for the outlet end of the flushing water pipe and the inlet end of the waste pipe
Inventor: CUMMINGS STEPHEN JOHN
Filed: 2009-02-16
Abstract: A toilet pan installation bracket assembly 10, the assembly 10 including: a first bracket portion 12 adapted for fixing to a wall W; a second bracket portion 14; a flexible flushing water conduit 36 having an outlet end 36' supported by the second portion 14; a third bracket portion 16; and a flexible waste conduit 38 having an inlet end supported by the third portion 38, wherein the second 14 and third portions 16 are fixed relative to the first portion 12.
Patent NZ-575575-A (NZ)
Title: Succinate and malonate salt of trans-4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperazine and the use as a medicament
Inventor: LOPEZ DE DIEGO HEIDI
IPC: C07D295/073
Filed: 2004-08-18
Abstract: Disclosed is a method for manufacturing 4-((1R,3S)-6-chloro-3-phenylindan-1-yl)-1,2,2-trimethylpiperzine (formula I, Compound I) or a salt thereof, which method comprises conversion of the compound of formula Va in cis-configuration to the compound of formula I. Also disclosed are the compounds of formula Va and formula VI. (62) Divided Out of 544715
Patent NZ-575984-A (NZ)
Title: Dosing siphon that automatically repeats the siphon action once the system has been initially charged
Inventor: KAY DAVID GODFREY
IPC: B65G65/30
Filed: 2009-04-03
Abstract: An automatically resetting dosing siphon (1) is disclosed. When water in a tank (2) rises to a first predetermined level the siphon (1) empties the tank (2) down to a second predetermined level. The siphon (1) must be pre-charged to operate by filling the main chamber (6) with water. In normal operation, as the tank (2) fills from the water inlet (17) the rising water first fills the siphon inlet (3) and then the bell (4). When the open end (10) of the balance tube (9) is covered, air can no longer escape from the bell (4) and is trapped as an air lock. As the water continues to rise the air lock is driven down the riser tube (5) within the main trap (6). When the airlock finally emerges for the riser tube (5) the equivalent volume of water is displaced out the water outlet (7) causing the siphon to start working. The air leaves the siphon via the air relief trap (12). Water will continue to flow from the tank (2) until the level is that of the siphon water inlet (3). At which point air enters the siphon (1) stopping the flow but leaving the main chamber (6) filled with water ready for the next time the rising water level triggers the siphon (1). The siphon (1) may be installed inside or outside the tank (2).
Patent NZ-579572-A (NZ)
Title: A downpipe diverter with fluting for diverting flow of a fluid in a pipe
Inventor: LUCAS CHRISTOPHER FRANCIS
IPC: E04D13/08
Filed: 2009-09-08
Abstract: An apparatus for diverting flow of a fluid in a pipe (1) is disclosed. The apparatus includes a flexible mid portion (2), and a first coupling for a pipe (4, 5). The coupling has a first portion (6, 9) with a contact surface configured to engage with a pipe of a first size, and a second portion (7, 8) with a contact surface configured to mate with a pipe of a second size. The apparatus is characterized in that the contact surfaces of the coupling are configured with a friction surface, where the friction surface is fluting (11, 12).
Patent NZ-581013-A (NZ)
Title: Multi-LED light fixture with comprising an arrangement for rigid wiring
Inventor: WILCOX KURT S
IPC: B60Q1/00
Filed: 2008-05-02
Abstract: Disclosed is an LED light fixture (10) including a housing (20) defining a chamber (24), an LED module (30) and a heat sink (50). The housing (20) includes an aperture (26). The LED module (30) is outside the chamber (24) and adjacent to the housing (20) and includes a mounting board (32) with a plurality of LED packages (34) mounted thereon and a cover (36) over the mounting board (32). The cover (36) forms a module interior and is configured to expose the LED packages (34). A rigid wireway (60) is arranged between the LED module (30) and the housing (20) and defines a passageway between the module interior and the chamber (24). The rigid wireway (60) includes a distal end in sealing engagement about said aperture (26). The LED light fixture (10) further includes a heat sink (50) connected to the LED module (30) wherein the heat sink (50) is attached to the mounting board (32) opposite the module interior.
Patent NZ-581931-A (NZ)
Title: Reporting channel quality information in a format adaptable to antenna configuration
Inventor: SUNDIN TOMAS
IPC: H04B7/06
Filed: 2007-07-06
Abstract: Disclosed is a mobile terminal device (401) for use in a wireless communications system (420). The mobile terminal device (401) is comprised of a receiver (405) for receiving a signal (404) from M number of transmit antennas (403-1, 403-2, 403-3, 403-4), which signal (404) includes a number of subcarriers (412). The mobile terminal device (401) is also comprised of a processing unit (406) for determining a channel quality indicator, CQI, reporting format for a collection of said subcarriers (412). This determination is based on a selected transmit antenna configuration associated with said collection of subcarriers (412). The processing unit (406) also determines PCQI number of CQI values (409) relating to said collection of subcarriers (412) in accordance with a determined CQI reporting format. The processing unit (406) is arranged to adapt the CQI reporting format to the selected transmit antenna configuration such that the granularity of CQI reporting depends on the number of transmit antennas (403-1, 403-2, 403-3, 403-4) of the selected transmit antenna configuration. The mobile terminal device (401) is further comprised of a transmitter (407) for transmitting the PCQI CQI values (409) to a base station (400) in a feedback signal (408).
Patent NZ-584692-A (NZ)
Title: Substituted n-phenyl-bipyrrolidine ureas and therapeutic use thereof
Inventor: CZECHTIZKY WERNGARD
IPC: A61K31/4025
Filed: 2008-10-14
Abstract: Disclosed herein are substituted N-phenyl-bipyrrolidine ureas of formula (I), wherein the substituents are as defined within the specification, methods for their preparation, compositions comprising said compounds and uses thereof. Said compounds are modulators of H3 receptors and therefore are useful in the treatment and/or prevention of diseases modulated by H3 receptors such as diseases associated with the central nervous system, sleep related disorder, dementia, Alzheimer's disease, multiple sclerosis, cognitive disorder, attention deficit hyperactivity disorder and depression.
Patent NZ-586074-A (NZ)
Title: LCLRP peptides, constructs and uses thereof
Inventor: KRISSANSEN GEOFFREY WAYNE
IPC: A61K38/00
Filed: 2010-06-10
Abstract: NZ 586074 Disclosed is a peptide consisting of a first segment (A) selected from the group of peptides consisting the amino acid sequence of any one of: LCLRP (SEQ ID NO 1); LCLRPVG (SEQ ID NO 2); LCLRPVGAESRGRPV (SEQ ID NO 90); LCLRPVGAESRGRPVSGPFG (SEQ ID NO 6); LCLRPVGAESRGRPVSGPF (SEQ ID NO 71); LCLRPVGAESRGRPVSGP (SEQ ID NO 70); LCLRPVGAESRGRPVSG (SEQ ID NO 69); LCLRPVGAESRGRPVS (SEQ ID NO 68); LCLRPVGAESRGRPV (SEQ ID NO 67); LCLRPVGAESRGRP (SEQ ID NO 66); LCLRPVGAESRG (SEQ ID NO 65); LCLRPVGAER (SEQ ID NO 64); MAARLCCQLDPARDVLCLRP (SEQ ID NO 3); or a functionally equivalent variant of any one thereof; and optionally a second segment (B) connected to the first segment and comprising one or more heterologous amino acids such that the peptide is a fusion peptide. The disclosed peptide is used for increasing the cell membrane permeability of a compound.
Patent NZ-586444-A (NZ)
Title: New 2-mercaptocyclopentanecarboxylic acid compounds, a process for their preparation and pharmaceutical compositions containing them
Inventor: GLOANEC PHILIPPE
IPC: A61P25/28
Filed: 2010-06-25
Abstract: 2-Mercaptocyclopentanecarboxylic acid compounds of formula (I) and their optical isomers and acid addition salts are disclosed, wherein R1 is H or COR4; R4 is C1-C6 alkyl or aryl or cyclopentane carboxylic acid group of formula (A), wherein R2 is NR5R6; R5 and R6 are H, C1-C6 alkyl, group, a nitrogen-containing heterocyclic group, aryl or heteroaryl; R3 is H or C1-C6 alkyl; m represents an integer 1 to 6; and n represents an integer 0, 1, or 2. A composition comprising a compound of formula (I) in combination with one or more inert, non-toxic, pharmaceutically acceptable excipients or carriers is also disclosed. These compounds have the activity as a thrombin-activatable fibrinolysis inhibitor (TAFI) and are suitable for use in the prevention, secondary prevention or treatment of myocardial infarction, angina pectoris, arteritis of the lower limbs, venous thromboses, pulmonary embolism, cerebrovascular accidents, vascular complications of diabetes, aortic aneurysms and dementias.
Patent NZ-591101-A (NZ)
Title: Randomic vibration for treatment of blood flow disorders
Inventor: MENON CARLO
IPC: A61H1/00
Filed: 2009-07-10
Abstract: 591101 A therapeutic device (10) is disclosed for treatment of a blood flow disorder. The device comprises a vibrator operable to produce a mechanical vibration and to transmit the vibrations to an external human body surface. At least one vibration parameter, such as vibration frequency, vibration displacement amplitude, vibration force, vibration directivity, vibration wave shape, vibration duty factor, or vibration pattern is randomly varied over time. The device is intended as part of a first line emergency response system for the treatment of blood flow disorders, especially acute thrombotic and/or vasospastic vascular obstructions.
Patent NZ-593536-A (NZ)
Title: Quinoline derivatives and methods of use
Inventor: BAELL JONATHAN BAYLDON
IPC: A61K31/435
Filed: 2009-12-17
Abstract: Disclosed herein are quinoline compounds of formula I, wherein the substituents are as defined within the specification, processes for their preparation, compositions comprising said compounds and uses thereof. Said compounds are useful in the treatment or prevention of a disease or condition caused, exacerbated by or resulting from an excess of, or undesired activation of, platelets in a patient, as such is useful for treating essential thrombocythemia, polycythemia vera, restenosis, perioperative antiplatelet therapy and device-associated thrombi and also small cell lung cancer. Examples of particularly preferred compounds include: 6-(1-(Benzo[d]thiazol-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl)-3-(3-(4-(dimethylamino)phenoxy)propoxy)picolinic acid 2-(1-(benzo[d]thiazol-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl)thiazole-4-carboxylic acid; 6-(1-(benzo[d]thiazol-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl)-3-hydroxypicolinic acid; 6-(4-(benzo[d]thiazol-2-ylcarbamoyl)-1-methyl-1,2,3,4-tetrahydroquinoxalin-6-yl)picolinic acid; 6-(1-(benzo[d]thiazol-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl)-3-(1-benzyl-1H-pyrazol-4-yl)picolinic acid; (E)-2-(1-(benzo[d]thiazol-2-ylcarbamoyl)-1,2,3,4-tetrahydroquinolin-7-yl)-5-(prop-1-enyl)thiazole-4-carboxylic acid; 5-(3-(4-(aminomethyl)phenoxy)propyl)-2-(4-(benzo[d]thiazol-2-ylcarbamoyl)-3,4-dihydro-2H-benzo[b][1,4]oxazin-6-yl)thiazole-4-carboxylic acid.
Patent NZ-594123-A (NZ)
Title: Saccharomyces cerevisiae strains with phytosanitary capabilities
Inventor: PUJOS PHILIPPE
IPC: A01N63/32
Filed: 2010-01-26
Abstract: Disclosed is a Saccharomyces cerevisiae strain, characterized in that it is selected from strain No. I-3936 deposited on March 4th 2008 at the CNCM, strain No. I-3937 deposited on March 4th 2008 at the CNCM, strain No. I-3938 deposited on March 4th 2008 at the CNCM, and strain No. I-3939 deposited on March 4th 2008 at the CNCM. Also disclosed is a phytosanitary composition comprising said S.cerevisiae strains.
Patent NZ-596077-A (NZ)
Title: Metal edging for concrete slabs with fixing plates
Inventor: UNDERWOOD DANIEL CHARLES
IPC: E01C11/06
Filed: 2011-10-28
Abstract: Metal edging 10 for concrete slabs, comprises first and second edging strips running parallel to one another, the first edging strip 11 having a longitudinally extending web 21 and an upper flange 13, the second edging strip 12 having a longitudinally extending web 22 and an upper flange 14 mating the flange 13 of the first edging strip 11, the strips being set in back to back relationship with upper flanges of the strips being in alignment and extending in opposite transverse directions. A fixing plate 25 extends from one of the strips, and is adapted to secure the edging 10 to formwork 26 located below the edging 10. The fixing plate 25 has a horizontal slide plate overlapping and slidable across a lower edge of one of the strips and a vertical plate adapted to fix the vertical plate to the formwork 26.
Patent NZ-604014-A (NZ)
Title: Injection device with needle shield
Inventor: ROBERTS GARETH
IPC: A61M5/32
Filed: 2011-06-21
Abstract: 604014 An injection device (D) comprises a pre-filled syringe (2) and a safety device. The pre-filled syringe comprises a barrel (2.3) with an inner cavity (2.3.1) in fluid communication with a hypodermic needle (2.1) attached to a distal end of the pre-filled syringe and a piston (2.4) fluid-tightly sealing a proximal end of the inner cavity. The safety device comprises a support body (1.2) for retaining the pre-filled syringe therein, an outer body (1.3) operably connected to the piston, a needle shield (1.1) and a releasable retaining means (R). The retaining means comprises a radial projection (1.2.3) and a longitudinal recess (1.3.2) adapted to receive the radial projection. The radial projection is connected to or integral part of one of the support body or the outer body and a longitudinal recess formed into the other of the support body or the outer body. The needle shield, the support body and the outer body are telescopable relative to each other. The piston is movable in a distal direction to expel a medicament contained in the inner cavity through the hypodermic needle by a manual actuation of the outer body. A telescoping movement of the outer body with respect to the support body is restricted by the retaining means when the needle shield is moved with respect to the support body in a proximal direction from an initial position (I) towards a retracted position. The retaining means is released when the needle shield reaches the retracted position allowing for a telescoping movement of the outer body with respect to the support body to expel the medicament contained in the pre-filled syringe through the hypodermic needle. The longitudinal recess comprises a first section (1.3.2.1) and a second section (1.3.2.2) separated by a web (1.3.3) from each other. The radial projection engages the first section of the longitudinal recess to prevent the telescoping movement of the outer body with respect to the support body until the needle shield has reached a retracted position. The radial projection has to overcome the web before the outer body is allowed to telescope with respect to the support body. A retention force required to deflect the radial projection exceeds a force required to move the needle shield with respect to the support body from the initial position to the retracted position.
Patent NZ-605393-A (NZ)
Title: Collapsible container
Inventor: SEENEY LLOYD ANDREW
IPC: B65D19/06
Filed: 2012-01-09
Abstract: A collapsible bulk container which includes a base tray defining an upper face and a perimeter lip, and a lid which defines a perimeter lip and which is arranged partially enclose the assembled container. The lid has the same dimensions as the base tray. The container also has a plurality of separate wall sections, each wall section having an interior surface, an exterior surface and two side edges, and two or more sliding connection brackets. Each bracket is associated with a side edge of a wall section. The sliding connection brackets have a complementary form which allows two brackets to engage with one another when slid into one another. In a collapsed state the lid and base tray enclose horizontally orientated wall sections.
Patent NZ-614345-A (NZ)
Title: Method and use for measurement of nk cell activity
Inventor: LEE JAE MYUN
IPC: G01N33/68
Filed: 2012-02-10
Abstract: Disclosed is a method of measuring NK cell activity, comprising: stimulating NK cells in a whole blood sample thereby artificially activating the NK cells to generate NK cell-secreting cytokines; and measuring an amount of the NK cell-secreting cytokines in the whole blood sample. Use of at least one stimulating cytokine, lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (poly I:C) in the manufacture of a kit for measuring NK cell activity, wherein the at least one stimulating cytokine, lipopolysaccharide (LPS) or polyinosinic:polycytidylic acid (poly I:C) is provided for stimulating NK cells in a whole blood sample and thereby artificially activating the NK cells to generate NK cell-secreting cytokines, and wherein an amount of the NK cell-secreting cytokines in the whole blood sample is used to measure NK cell activity .